We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

AGILENT

Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling... read more Featured Products: More products

Download Mobile App




Molecular Diagnostic Tool Evaluated for Malaria

By LabMedica International staff writers
Posted on 03 Mar 2014
Print article
Image: The Stratagene Mx3000P real-time PCR system (Photo courtesy of Agilent).
Image: The Stratagene Mx3000P real-time PCR system (Photo courtesy of Agilent).
The diagnostic potential of a recently developed photo-induced electron transfer fluorogenic primer (PET) real-time polymerase chain reaction (PCR) called PET-PCR has been investigated for diagnosing malaria.

Accurate diagnosis of malaria infections remains challenging, especially in the identification of submicroscopic infections and molecular diagnostic tools that are inexpensive, sensitive enough to detect low-level infections are needed in laboratory settings of resource-limited countries.

Scientists at the University of Georgia (Athens, GA, USA) working with colleagues in East Africa, obtained 303 blood samples from a survey conducted in the Iringa region of Tanzania. Both thick and thin smears were prepared for each sample and DNA was extracted and isolated as well. All samples were screened using the multiplex PET-PCR assay designed to detect Plasmodium genus and P. falciparum initially in laboratory in Tanzania and then repeated at a reference laboratory, the Centers of Disease Control and Prevention (CDC; Atlanta, GA, USA).

A subset of the samples were tested in a blinded fashion to find the sensitivity and specificity of the PET-PCR compared to the nested 18S ribosomal ribonucleic acid (rRNA) PCR. The Stratagene Mx3000P real-time PCR system (Agilent; Santa Clara, CA, USA) was used to test all samples in both the Ifakara Health Institute (Dar es Salaam; Tanzania) and at the CDC.

Twenty-seven samples out of the 303 tested were found to be positive for both P. falciparum and Plasmodium spp. by PET-PCR when performed in both laboratories. Microscopy detected 11 positive samples (3.63%) among the 303 samples tested, and these microscopy positive samples were confirmed to be positive by PET-PCR. In addition, 16 microscopy-negative samples were found to be positive for both P. falciparum and Plasmodium spp. by PET-PCR. The data showed 100% sensitivity and specificity for the PET-PCR assay and 40% sensitivity and 100% specificity for microscopy.

As the goal moves towards malaria elimination, newer tools that are able to detect all malaria cases, including low-density infections not detectable by microscopy, or rapid diagnostic tests (RDTs), and that are applicable to large-scale screening, are required. The authors concluded that PET-PCR as a new molecular diagnostic tool has similar performance characteristics as commonly used PCR methods, but is less expensive, easier to use, and suitable for large scale-surveillance studies in developing country settings. The study was published on January 27, 2014, in the Malaria Journal.

Related Links:

University of Georgia
Agilent
Ifakara Health Institute



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.